Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:14 pm Sale | 13G | Aimmune Therapeutics Inc. AIMT | Palo Alto Investors LP | 0 0.000% | -3,380,441 (Position Closed) | View |
| 2020-10-13 10:48 am Sale | 13D | Aimmune Therapeutics Inc. AIMT | Societe des Produits Nestle S.A. | 100 100.000% | -12,813,147 (-100.00%) | View |
| 2020-08-31 06:47 am Purchase | 13D | Aimmune Therapeutics Inc. AIMT | Societe des Produits Nestle S.A. | 12,813,247 19.600% | 12,813,247 (New Position) | View |
| 2020-04-24 4:30 pm Unchanged | 13D | Aimmune Therapeutics Inc. AIMT | Nestle Health Science US Holdings Inc. | 12,727,113 19.600% | 0 (Unchanged) | View |
| 2020-02-14 1:30 pm Purchase | 13G | Aimmune Therapeutics Inc. AIMT | PRICE T ROWE ASSOCIATES INC | 5,622,538 8.800% | 850,629 (+17.83%) | View |
| 2020-02-14 1:16 pm Unchanged | 13G | Aimmune Therapeutics Inc. AIMT | Palo Alto Investors LP | 3,380,441 5.340% | 0 (Unchanged) | View |
| 2020-02-13 9:20 pm Sale | 13G | Aimmune Therapeutics Inc. AIMT | Foresite Capital Fund II L.P. | 0 0.000% | -3,678,471 (Position Closed) | View |
| 2020-02-12 4:24 pm Purchase | 13G | Aimmune Therapeutics Inc. AIMT | Longitude Capital Partners II LLC | 6,215,278 9.800% | 23,750 (+0.38%) | View |
| 2020-02-12 11:13 am Purchase | 13G | Aimmune Therapeutics Inc. AIMT | VANGUARD GROUP INC | 4,040,835 6.380% | 365,761 (+9.95%) | View |
| 2020-02-11 11:57 am Purchase | 13D | Aimmune Therapeutics Inc. AIMT | Nestle Health Science US Holdings Inc. | 12,727,113 19.900% | 1,000,000 (+8.53%) | View |
| 2020-02-05 11:25 am Sale | 13G | Aimmune Therapeutics Inc. AIMT | BlackRock Inc. BLK | 3,676,895 5.800% | -46,216 (-1.24%) | View |